DSIJ Mindshare

Alembic Pharma receives USFDA nod for tablets treating depression

Anthony Fernandes 0 1219 Article rating: 4.7

Alembic Pharma announced that it has received the final approval from US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) of Vilazodone Hydrochloride Tablets, 10 mg, 20 mg and 40 mg. The approved ANDA is equivalent to the reference listed product, Viibryd Tablets, 10 mg, 20 mg and 40 mg of Allergan Sales Limited.

RSS
First929394959799100101Last
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR